Multiple recent studies focused on HIV and diabetes, looking at incidence of diabetes among patients with HIV, the effectiveness of medications in patients with both conditions, and efforts to improve nutrition in patients with one or both conditions
Two recent studies looked at the incidence of hypoglycemia among patients with diabetes around the world, while another offered an intervention to reduce hypoglycemia in patients with impaired awareness of it.
Recent studies looked at biomarkers to predict diabetes, characteristics of patients who developed type 1 diabetes during adulthood, and use of oral insulin to try to prevent type 1 diabetes.
Recent industry-funded studies compared degludec, an ultralong-acting, once-daily basal insulin, to basal insulin glargine on outcomes including hypoglycemia, glucose control, and cardiovascular events.
Recent studies looked at vitamin D supplementation, peer mentoring, and physician referrals to diabetes prevention programs among patients with prediabetes.
Data from the Diabetes Prevention Program (DPP) Outcomes Study showed little effect of diabetes prevention efforts on patients' cognition or coronary artery calcium, according two recent studies.
From the ancient Egyptians to current pilot projects, two recent articles in the New England Journal of Medicine reviewed the history and current state of diabetes care.
Recent trials examined the potential effects of probiotic supplements and sucrose octasulfate dressings.
Studies published in the past month looked at statin prescriptions for patients with diabetes and osteoporotic fracture risk in women with diabetes.
Evidence on possible risks of pioglitazone, including bladder cancer, prostate cancer, and fractures, made the news in the past month.